121 related articles for article (PubMed ID: 1835198)
21. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
Watts IS; Wharton KA; White BP; Lumley P
Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
[TBL] [Abstract][Full Text] [Related]
22. Sepsis-associated renal vasoconstriction: potential targets for future therapy.
Badr KF
Am J Kidney Dis; 1992 Sep; 20(3):207-13. PubMed ID: 1519601
[TBL] [Abstract][Full Text] [Related]
23. The effect of thromboxane A2 receptor antagonism on amphotericin B-induced renal vasoconstriction in the rat.
Hardie WD; Ebert J; Frazer M; Takahashi K; Badr K
Prostaglandins; 1993 Jan; 45(1):47-56. PubMed ID: 8424133
[TBL] [Abstract][Full Text] [Related]
24. Leukotriene D4- and prostaglandin F2 alpha-induced airflow obstruction and airway plasma exudation in guinea-pig: role of thromboxane and its receptor.
Arakawa H; Lötvall J; Kawikova I; Löfdahl CG; Skoogh BE
Br J Pharmacol; 1993 Sep; 110(1):127-32. PubMed ID: 8220872
[TBL] [Abstract][Full Text] [Related]
25. Lipoxin A4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: evidence for competition at a common receptor.
Badr KF; DeBoer DK; Schwartzberg M; Serhan CN
Proc Natl Acad Sci U S A; 1989 May; 86(9):3438-42. PubMed ID: 2541448
[TBL] [Abstract][Full Text] [Related]
26. The role of thromboxane in two-kidney, one-clip Goldblatt hypertension in rats.
Himmelstein SI; Klotman PE
Am J Physiol; 1989 Aug; 257(2 Pt 2):F190-6. PubMed ID: 2527469
[TBL] [Abstract][Full Text] [Related]
27. Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2.
Filep JG; Fournier A; Földes-Filep E
Br J Pharmacol; 1994 Jul; 112(3):963-71. PubMed ID: 7921626
[TBL] [Abstract][Full Text] [Related]
28. Maximal blockade of TxA2 without compromised PGI2 formation; a superior profile of the TxA2 receptor blocking drug GR32191 over aspirin.
Lumley P; Keery RJ; Wharton KA; White BP; Watts IS
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():603-6. PubMed ID: 1825385
[No Abstract] [Full Text] [Related]
29. Interactions between nitric oxide and prostanoids in isolated perfused kidneys of the rat.
Ziyyat A; Zhang BL; Benzoni D
Br J Pharmacol; 1996 Sep; 119(2):388-92. PubMed ID: 8886425
[TBL] [Abstract][Full Text] [Related]
30. Acute effects of nifedipine in renal transplant recipients treated with cyclosporine or azathioprine.
Hilbrands LB; Hoitsma AJ; van Hamersvelt HW; Wetzels JF; Huysmans FT; Koene RA
Am J Kidney Dis; 1994 Nov; 24(5):838-45. PubMed ID: 7977327
[TBL] [Abstract][Full Text] [Related]
31. Leukotriene C4 and D4 contract rat glomerular mesangial cells.
Simonson MS; Dunn MJ
Kidney Int; 1986 Oct; 30(4):524-31. PubMed ID: 3465969
[TBL] [Abstract][Full Text] [Related]
32. Effect of endogenously produced leukotrienes and thromboxane on renal vascular resistance in rabbit hydronephrosis.
Albrightson CR; Evers AS; Griffin AC; Needleman P
Circ Res; 1987 Oct; 61(4):514-22. PubMed ID: 2820607
[TBL] [Abstract][Full Text] [Related]
33. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.
Lefort J; Rotilio D; Vargaftig BB
Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375
[TBL] [Abstract][Full Text] [Related]
34. Renal and systemic hemodynamic responses to intravenous infusion of leukotriene C4 in the rat.
Badr KF; Baylis C; Pfeffer JM; Pfeffer MA; Soberman RJ; Lewis RA; Austen KF; Corey EJ; Brenner BM
Circ Res; 1984 May; 54(5):492-9. PubMed ID: 6722998
[TBL] [Abstract][Full Text] [Related]
35. L-649,923: an antagonist of cardiac and vascular leukotriene D4 receptors.
Sirén AL; Eimerl J; Feuerstein G
J Cardiovasc Pharmacol; 1989 Feb; 13(2):210-7. PubMed ID: 2468948
[TBL] [Abstract][Full Text] [Related]
36. Sequential agonist activation and site-specific mediation of acute cyclosporine constriction in rat renal arterioles.
Lanese DM; Falk SA; Conger JD
Transplantation; 1994 Dec; 58(12):1371-8. PubMed ID: 7809931
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin II influences the renal hemodynamic response to blockade of thromboxane A2 and prostaglandin H2 receptors.
Yamaguchi Y; Fenoy FJ; Roman RJ; Nasjletti A
J Pharmacol Exp Ther; 1992 Dec; 263(3):905-9. PubMed ID: 1469647
[TBL] [Abstract][Full Text] [Related]
38. Role of platelet-activating factor in renal function in normal rats and rats with bilateral ureteral obstruction.
Reyes AA; Klahr S
Proc Soc Exp Biol Med; 1991 Oct; 198(1):572-8. PubMed ID: 1891471
[TBL] [Abstract][Full Text] [Related]
39. Platelet-activating factor mediates endotoxin-induced acute renal insufficiency in rats.
Wang J; Dunn MJ
Am J Physiol; 1987 Dec; 253(6 Pt 2):F1283-9. PubMed ID: 2827506
[TBL] [Abstract][Full Text] [Related]
40. Vascular responses to leukotriene B4, C4 and D4 following FPL 55712, indomethacin, saralasin, phentolamine and verapamil in the conscious rat.
Filep J; Földes-Filep E; Frölich JC
Br J Pharmacol; 1987 Feb; 90(2):431-9. PubMed ID: 3030486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
